Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 30, 2000 - Issue 11
Submit an article Journal homepage
42
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Mass spectrometric and NMR characterization of metabolites of roxifiban, a potent and selective antagonist of the platelet glycoprotein IIb/IIIa receptor

A. E. Mutlib Drug Metabolism and Pharmacokinetics Section
,
S. Diamond Department of Chemical and Physical Sciences, DuPont Pharmaceuticals Company, Stine-Haskell Research Center, PO Box 30, Elkton Road, Newark, DE 19714, USA
,
J. Shockcor Drug Metabolism and Pharmacokinetics Section
,
R. Way Department of Chemical and Physical Sciences, DuPont Pharmaceuticals Company, Stine-Haskell Research Center, PO Box 30, Elkton Road, Newark, DE 19714, USA
,
G. Nemeth Drug Metabolism and Pharmacokinetics Section
,
L. Gan Department of Chemical and Physical Sciences, DuPont Pharmaceuticals Company, Stine-Haskell Research Center, PO Box 30, Elkton Road, Newark, DE 19714, USA
&
D. D. Christ Drug Metabolism and Pharmacokinetics Section
 show all
Pages 1091-1110 | Published online: 22 Sep 2008

References

  • BATT, D. G., HOUGHTON, G. C., DANEKAR, W. F. and JADHAV, P. K., 1999, Synthesis of cis- and trans-isomers of an isoxazoline ring-hydroxylated metabolite of roxifiban, a platelet glycoprotein IIb/IIIa receptor antagonist Journal of Organic Chemistry (in press).
  • LINDON, J. C., NICHOLSON, J. K., SIDELMANN U. G. and WILSON I. D., 1997, Directly coupled HPLC-NMR and its application to drug metabolism. Drug Metabolism Reviews, 29, 705–747.
  • MUTLIB, A. E., STRUPCZEWSKI, J. T. and CHESSON, S. M., 1995, Application of hyphenated LC/NMR and LC/MS techniques in rapid identification of in vitro and in vivo metabolites of iloperidone. Drug Metabolism and Disposition, 23, 951–964.
  • MEULDERMANS, W., HENDRICKX, J., MANNENS, G., LAVRIJSERI, K., JANSSEN, C., BRACKE, J. and JEUNE, L. L., 1994, The metabolism and excretion of risperidone after oral administration in rats and dogs. Drug Metabolism and Disposition, 21, 129–136.
  • MANNENS, G., HUANG, M., MEULDERMANS, W., HENDRICKX, J., WOESTENBORGHS, R. and HEYKANTS, J., 1993, Absorption, metabolism and excretion of risperidone in humans. Drug Metabolism and Disposition, 21, 1134–1141.
  • SHOCKCOR, J. P., WURM, R. M., FRICK, L. W., SANDERSON, P. N., FARRANT, R. D., SWEATMAN, B. C. and LINDON, J. C., 1996, HP LC-NMR identification of the human urinary metabolites of ( — )-cis-5-fluoro-1- [2 -(hydroxymethyl)-1,3-oxhiolan-5 -yl] cytosine, a nucleoside analogue active against human immunodeficiency virus (HIV). Xenobiotica, 26,189–199.
  • SPRAUL, M., HOFMANN, M., WILSON, I. D., LENZ, E., NICHOLSON, J. K. and LINDON, J. C. 1993, Coupling of HPLC with 19F- and 11-1-NMR spectroscopy to investigate the human urinary excretion of flurbiprofen metabolites. Journal of Pharmaceutical and Biomedical Applications, 11,1009–1015.
  • SMALLCOMBE, S. H., PATT, S. L. and KEIFER, P. 1995, WET solvent suppression and its applications to LC NMR and high-resolution NMR spectroscopy. Journal of Magnet k Resonance A, 117, 295–303.
  • STIFF, D. D., ROBICHEAU, J. T. and ZEMAITIS, M. A., 1992, Reductive metabolism of the anticonvulsant agent zonisamide, a 1,2 -benzisoxazole derivative. Xenobiotica, 22, 1–11.
  • STIFF, D. D. and ZEMAITIS, M. A., 1990, Metabolism of the anticonvulsant agent zonisamide in the rat. Drug Metabolism and Disposition, 18, 888–894.
  • STILL, W. C., KAHN, M. and MITR A., 1978, Rapid chromatographic technique for preparative separations with moderate resolution. Journal of Organic Chemistry, 43,2923–2925.
  • TUCKER, C. E., DAVIDSON, J. and KNOCHEL, P., 1992, Mild and stereoselective hydroborations of functionalized alkynes and alkenes using pinacolborane. Journal of Organk Chemistry, 57, 3482–3485.
  • WITYAK, J., SIELECKI, T. M., PINTO, D. J., EMMETT, G., SZE, J. Y., Liu, J., TOBIN, A. E., WANG, S. and JIANG, B., 1997, Discovery of potent isoxazoline glycoprotein H1D-Hia receptor antagonists. Journal of Medicinal Chemistry, 40, 50–60.
  • XUE, C. B., RAFALSKI, M., RODERICK, J., EYERMANN, C. J., MOUSA, S., OLSON, R. E. and DE GRADO, W. F., 1996, Design, synthesis and in vitro activities of a series of benzimidazole/benzoxazole glycoprotein H1D/Hia inhibitors. Bioorgank Medicinal Chemistry Letters, 6, 339–344.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.